В постели с бактериями. История, наука и секреты микроскопических существ, о которых не принято говорить - Парк Айна

5. Semeniuk I., Reverby S. A shocking discovery. Nature. 2010 Oct 7;467 (7316):645.

6. Presidential Commission for the Study of Bioethical Issues. Ethically Impossible: STD Research in Guatemala from 1946 to 1948. Washington, D. C.; 2011. Available at: https://bioethicsarchive.georgetown.edu/pcsbi/sites/default/files/Ethically%20Impossible%20(with%20linked%20historical%20documents)%202.7.13.pdf. Accessed March 2, 2019.

7. Zenilman J. The Guatemala sexually transmitted disease studies: what happened. Sex Transm Dis. 2013 Apr;40(4):277–9.

8. Castillo M. U.S. Rejects Guatemalans’ STD lawsuit, offers aid. CNN. January 10, 2012. Available at: https://www.cnn.com/2012/01/10/world/americas/us-guatemala-std-experiments/index.html. Accessed March 2, 2019.

9. United States Department of State. Tort claims against the U.S. Department of State. Available at: https://www.state.gov/s/l/3202.htm. Accessed March 2, 2019.

10. Stempel J. Johns Hopkins, Bristol-Myers must face $1B in syphilis infections lawsuit. Reuters Health Information. Available at: https://www.reuters.com/article/us-maryland-lawsuit-infections/johns-hopkins-bristol-myers-must-face-1-billion-syphilis-infections-suit-idUSKCN1OY1N3. Accessed January 19, 2019.

11. Philippines Statistics Authority. 2010 population of Olongapo City is twice its population forty years ago. July 10, 2013. Available at: https://psa.gov.ph/content/2010-population-olongapo-city-twice-its-population-forty-years-ago-results-2010-census. Accessed March 19, 2019.

12. Hawaii Tourism Authority. News release HTA: Hawaii visitor statistics released for 2018. Available at: https://governor.hawaii.gov/newsroom/latest-news/news-release-hta-hawaii-visitor-statistics-released-for-2018/. Accessed March 29, 2019.

13. Centers for Disease Control and Prevention. STD success stories: battling antibiotic-resistant gonorrhea: a timeline of coordinated teamwork. Available at: https://www.cdc.gov/std/products/success/Hawaii-SUCCESS-STORIES.pdf. Accessed March 21, 2019.

14. Unemo M., Shafer W. M. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. CMR. Jun 2014;27(3):587–613.

15. Elwell L.P., Roberts M., Mayer L.W., Falkow S. Plasmid-mediated beta-lactamase production in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1977 Mar;11(3):528–33.

16. Barbee L. A. Preparing for an era of untreatable gonorrhea. Curr Opin Infect Dis. 2014 Jun;27(3):282–7.

17. Habel, Melissa A., Jami S. Leichliter, Patricia J. Dittus, Ian H. Spicknall, and Sevgi O. Aral. 2018. “Heterosexual Anal and Oral Sex in Adolescents and Adults in the United States, 2011–2015.” Sexually Transmitted Diseases 45 (12): 775–782.

18. Chow E. P., Howden B. P., Walker S., Lee D., Bradshaw C. S., Chen M. Y., Snow A., Cook S., Fehler G., Fairley C. K. Antiseptic mouthwash against pharyngeal Neisseria gonorrhoeae: a randomised controlled trial and an in vitro study. Sex Transm Infect. 2017 Mar;93(2):88–93.

19. Emen8. Have we found a new weapon in the fight against gonorrhea? Available at: https://emen8.com.au/health/fitnessandbody/have-we-found-a-new-weapon-in-the-fight-against-gonorrhea/. Accessed March 29, 2019.

20. Sentencing Project. Criminal justice facts. Available at: https://www.sentencingproject.org/criminal-justice-facts/. Accessed March 29, 2019.

21. Thomas J. C., Sampson L. A. High rates of incarceration as a social force associated with community rates of sexually transmitted infection. J Infect Dis. 2005 Feb 1;191 Suppl 1:S55–60.

22. Aral S. O., Hughes J. P., Stoner B., et al. Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health. 1999;89(6):825–833.

23. Andrasik M. P., Nguyen H. V., George W. H., Kajumulo K. F. Sexual decision making in the absence of choice: the African American female dating experience. J Health Dispar Res Pract. 2014 Winter;7(7):66–86.

24. Dauria E. F., Elifson K., Arriola K. J., Wingood G., Cooper H. L.. Male incarceration rates and rates of sexually transmitted infections: results from a longitudinal analysis in a southeastern US city. Sex Transm Dis. 2015 Jun;42(6):324–8.

25. Dauria E.F., Oakley L., Arriola K. J., Elifson K., Wingood G., Cooper H. L. Collateral consequences: implications of male incarceration rates, imbalanced sex ratios and partner availability for heterosexual Black women. Cult Health Sex. 2015;17(10):1190–206.

26. Centers for Disease Control and Prevention. STDs in racial and ethnic minorities. Available at: https://www.cdc.gov/std/stats17/minorities.htm. Accessed March 28, 2019.

27. Potterat J. J, Rothenberg R. B., Woodhouse D. E., Muth J. B., Pratts C. I., Fogle J. S. 2nd. Gonorrhea as a social disease. Sex Transm Dis. 1985 Jan-Mar; 12(1):25–32.

28. Potterat J. J. “Socio-geographic” space and sexually transmissible diseases in the 1990s. Today’s Life Science. 1992; 4 (12); 16–22, 31.

ГЛАВА ДЕВЯТАЯ. ДОКОПАТЬСЯ ДО ПРАВДЫ

1. Enovid advertisement. Can Medical J. 17 February 1962;353.

2. Eig J. The Birth of the Pill: How Four Crusaders Reinvented Sex and Launched a Revolution. New York: W. W. Norton; 2014.

3. The pill: how is it affecting U.S. morals, family life? U.S. News & World Report. July 11, 1966.

4. Myers J. E., Sepkowitz K. A. A pill for HIV prevention: déjа vu all over again? Clin Infect Dis. 2013 Jun;56(11):1604–12. doi: 10.1093/cid/cit085. Epub 2013 Feb 13.

5. Grant R. M., Lama J. R., Anderson P. L., McMahan V., Liu A. Y., Vargas L., Goicochea P., Casapia M., Guanira-Carranza J. V., Ramirez-Cardich M. E., Montoya-Herrera O., Fernández T., Veloso V. G., Buchbinder S. P., Chariyalertsak S., Schechter M., Bekker L. G., Mayer K. H., Kallás E. G., Amico K. R., Mulligan K., Bushman L. R., Hance R. J., Ganoza C., Defechereux P., Postle B., Wang F., McConnell J. J., Zheng J. H., Lee J., Rooney J. F., Jaffe H. S., Martinez A. I., Burns D. N., Glidden D. V.; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30;363(27):2587–99.

6. Baeten J. M., Donnell D., Ndase P., Mugo N. R., Campbell J. D., Wangisi J., Tappero J. W., Bukusi E. A., Cohen C. R., Katabira E., Ronald A., Tumwesigye E., Were E., Fife K. H., Kiarie J., Farquhar C., John-Stewart G., Kakia A., Odoyo J., Mucunguzi A., Nakku-Joloba E., Twesigye R., Ngure K., Apaka C., Tamooh H., Gabona F., Mujugira A., Panteleeff D., Thomas K. K., Kidoguchi L., Krows M., Revall J., Morrison S., Haugen H., Emmanuel-Ogier M., Ondrejcek L., Coombs R. W., Frenkel L., Hendrix C., Bumpus N. N., Bangsberg D., Haberer J. E., Stevens W. S., Lingappa J. R., Celum C.; Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012 Aug 2;367(5):399–410.

7. Duran D. Truvada whores? Huffington Post. November 12, 2012. Updated February 2, 2016. Accessed September 10, 2017. Available at: https://www.huffpost.com/entry/truvada-whoresb2113588.

8. U.S. Public Health Service. Preexposure prophylaxis for the prevention of HIV infection the United States—2014. Available at: https://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf. Accessed September 1, 2017.

9. Smith D. K., Van Handel M., Wolitski R. J., Stryker J. E., Hall H. I., Prejean J., Koenig L. J., Valleroy L. A.. Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition – United States, 2015. MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1291–5.

10. AIDS Healthcare Foundation. PrEP: the revolution that didn’t happen. Available at: https://www.aidshealth.org/#/archives/24286. Accessed June 8, 2017.